Search results for: 'part 1'
- Related search terms
- part 01 00 00 00
- parts 01 00 00 00
- part market growth
- part solutions in the global hydrogen production market
- parts solutions in the global hydrogen production market
-
22 Jun 2020  |  North America  |  Technology Research
Analysing Sepsis Management Part I: Diagnosis
Recent Advances in Sepsis Diagnosis: PCR, Immunoassays, Sequencing and beyond
Sepsis diagnosis The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2020  |  Global  |  Technology Research
Analysing Sepsis Management Part II: Treatments
Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics
Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Aug 2020  |    |  Technology Research
Data Science Impacting the Pharmaceutical Industry Part II: Clinical trial Applications
Enabling faster analysis using advanced tools
Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through la...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028
GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth
Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Nov 2023  |  Global  |  Technology Research
Growth Opportunities in Obesity Drugs and Delivery Platforms
GLP-1-based Drugs, Along With Injector and Nanomaterial Delivery Platforms, Drive Transformational Industry Growth
The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 May 2024  |  Global  |  Technology Research
Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics)
Rising Popularity Among Tier 1 Pharma Companies and Technological Advances in Drug Delivery Push Biologics Development
There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 May 2024  |  Global  |  Market Research
Diabetes Care Devices, Forecast to 2028
Growth Opportunities in AI and GLP-1 will Drive the Expansion of Type 2 Diabetes Devices
This study provides a detailed overview of the global diabetes care device industry, which is witnessing a significant increase in demand due to the growing prevalence of diabetes across regions. The market, comprising both established players and emerging start-ups, is the site of fierce competition. OEMs are developing innovative, AI-equipped tec...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Aug 2020  |  Global  |  Technology Research
Data Science Impacting the Pharmaceutical Industry
Part I: Drug Discovery Applications
Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Sep 2019  |  Global  |  Technology Research
Emerging Therapeutics for Neurodegenerative Diseases Part II: Huntington's Disease and Amyotrophic Lateral Sclerosis (HD & ALS)
Novel Targeted Therapeutic Strategies Technologies Around Neurodegenerative Disorders - From Palliative to Future Interventions
At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2019  |  Global  |  Technology Research
Emerging Therapeutics for Neurodegenerative Diseases, Part I: Novel Targeted Therapeutic Strategies Technologies for Alzheimer's and Parkinson's Diseases
Novel Targeted Therapeutic Strategies Technologies Around Neurodegenerative Disorders - From Palliative to Future Interventions
At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...
$4,950.00
Special Price $3,712.50 save 25 %